EuroMedLab 2013

Milan, Italy – The 20th European Congress of Clinical Chemistry and Laboratory Medicine certainly lived up to its claim as the EU’s largest event of its kind – 2,407 visitors and 4,786 delegates from 101 countries plus 82 exhibitors fanned out or arranged themselves over the event’s 3,500 square metres, Hanna Politis reports

Photo: EuroMedLab 2013

More than 200 speakers presented technological advances that have resulted in detailed diagnostic findings for numerous diseases, among them the pattern of biomarkers that characterise diseases such as breast cancer or diabetes mellitus on a molecular level. This is made up of many different simultaneous measurements, which, thanks to new technologies, can be obtained with far more information than was available just a decade ago.

Also put forward: if a sufficient number of biomarkers is put into a meaningful context, diagnosing and treating a certain disease in a specific individual will become easier, safer and more precise, also bringing financial/budgetary benefits.

In addition, complete labora­tory automation through integrated robotics and IT solutions show that lab processes can be simplified, manual activities reduced and patient safety increased. Discussions also showed that, helped by intelligent robotics, new systems can automatically prepare blood samples for immediate analysis and post-analysis processing. The risks of mix-ups with samples or contamination through manual handling by laboratory staff are reduced. Short and predictable cycle times also mean faster clinical decisions.

Cancer also can be ever more specifically diagnosed, with laboratory medicine enabling individual treatments. Tests are increasingly non-invasive and free of undesired side effects, and results can be evaluated more quickly. Future health risks, such as those for breast cancer or diabetes, can be detected through blood tests. Experts agree that evidence-based laboratory medicine should be in­tro­duced quickly to medical practice.
 

03.08.2013

Read all latest stories

Related articles

Photo

Article • Connected laboratory

Digitisation and automation: Game-changers in histopathology?

Often referred to as the ‘Achilles’ heel’ of histopathology, the sample entry has posed considerable challenges in pre-analytics for several decades. We visited the Munich-based lab automation…

Photo

Article • The EFLM Strategic Conference

Placing the medical lab in a future landscape

The need to ensure that laboratory medicine can meet the future challenges of a rapidly changing healthcare environment sits at the core of an innovative strategic conference for this sector. The…

Photo

News • Lab-on-a-Chip

Breakthrough aims to help physicians detect cancer at nanoscale

IBM scientists have developed a new lab-on-a-chip technology that can, for the first time, separate biological particles at the nanoscale and could enable physicians to detect diseases such as…

Related products

ASP Lab Automation – Bench-top Decapper DeCap Pro

Sample Processing

ASP Lab Automation – Bench-top Decapper DeCap Pro

ASP Lab Automation AG
ASP Lab Automation – Recapper KapSafe

Sample Processing

ASP Lab Automation – Recapper KapSafe

ASP Lab Automation AG
ASP Lab Automation – Tube Sorter SortPro

Sample Processing

ASP Lab Automation – Tube Sorter SortPro

ASP Lab Automation AG
Beckman Coulter – DxA 5000

Automation

Beckman Coulter – DxA 5000

Beckman Coulter Diagnostics
Beckman Coulter - DxA 5000 Fit

Automation

Beckman Coulter - DxA 5000 Fit

Beckman Coulter Diagnostics
CliniSys | MIPS – DaVinci

Information Technology

CliniSys | MIPS – DaVinci

CliniSys | MIPS Deutschland GmbH
Subscribe to Newsletter